These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5736487)

  • 21. [Serum acid phosphatase determined by the radioimmunochemical method (P.A.P.-RIA): its diagnostic value in prostatic cancer].
    Marczyńska A; Kulpa J; Adamczyk B; Leńko J
    Przegl Lek; 1982 Sep; 39(8):573-6. PubMed ID: 6182582
    [No Abstract]   [Full Text] [Related]  

  • 22. Diagnostic value of serum ghrelin levels in prostate cancer.
    Mungan NA; Eminferzane S; Mungan AG; Yesilli C; Seckiner I; Can M; Ayoglu F; Akduman B
    Urol Int; 2008; 80(3):245-8. PubMed ID: 18480624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Value of the adenosine deaminase (ADA) isoenzyme system for forensic evidence: statistical dependability testing of paternity exclusion claims].
    Lefèvre H; Fiedler H; Niebuhr R
    Z Rechtsmed; 1972; 71(1):17-23. PubMed ID: 4638284
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical evaluation of a new kit (IMX PA Dainapack) for detection of serum prostate specific antigen].
    Machida T; Ohishi Y; Wada T; Akimoto S; Shimazaki J; Oda H; Yokoyama M; Tsukada T; Nakayama T; Akiyama A
    Hinyokika Kiyo; 1993 Oct; 39(10):977-84. PubMed ID: 7505519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Measurement of serum prostatic acid phosphatase (PAP) by Delfia PAP Kit using europium and clinical evaluation in patients with prostate cancer].
    Akimoto S; Ohki T; Ichikawa T; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1994 Nov; 40(11):987-93. PubMed ID: 7530404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An improved method for the assay of serum guanine deaminase activity.
    Quast NM; Clayson KJ; Strandjord PE
    Am J Med Technol; 1968 Sep; 34(9):513-21. PubMed ID: 5681411
    [No Abstract]   [Full Text] [Related]  

  • 27. Diagnostic accuracy and its limitations in prostatic cancer by means of transrectal ultrasonotomography.
    Watanabe H; Ohe H
    Ultrasound Med Biol; 1983; Suppl 2():541-4. PubMed ID: 6400278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The evaluation of the ratio of free and total serum prostate-specific antigen as an additional method in the diagnosis of prostatic cancer].
    Reznikov IuP; Mazanov GP; Sedova TN
    Urol Nefrol (Mosk); 1996; (6):41-3. PubMed ID: 9036610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnostic value of 10 systematized and ultrasound-guided transrectal prostatic biopsies].
    Ravery V; Billebaud T; Toublanc M; Boccon-Gibod L; Hermieu JF; Moulinier F; Blanc E; Delmas V; Boccon-Gibod L
    Prog Urol; 1998 Dec; 8(6):1012-7. PubMed ID: 9894260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A sensitive method for determination of serum guanine deaminase activity.
    Konttinen A
    Ann Med Exp Biol Fenn; 1969; 47(2):156-60. PubMed ID: 5360657
    [No Abstract]   [Full Text] [Related]  

  • 31. [Diagnostic value of cytology in prostatic neoplasms].
    Villarroya Rodríguez S; Valdivia Uría JG; Azua J; Gómez Aracil V; Romero Fernández FJ
    Actas Urol Esp; 1980; 4(5):255-60. PubMed ID: 7468350
    [No Abstract]   [Full Text] [Related]  

  • 32. [Diffusion weighted imaging: its diagnostic and differential value for prostate cancer].
    Shi H; Ding HY
    Zhonghua Nan Ke Xue; 2007 Jul; 13(7):605-9. PubMed ID: 17725302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Established oneself the detection of serum prostate specific antigen and application in clinical practice].
    Feng T; Dou CQ; Xia TL
    Zhonghua Wai Ke Za Zhi; 1994 Nov; 32(11):685-7. PubMed ID: 7539736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Transrectal prostate sonography in early cancer recognition].
    Frentzel-Beyme B; Aurich B; Drakopoulos A
    Computertomographie; 1983 Dec; 3(4):153-8. PubMed ID: 6199109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nuclear magnetic resonance tomography in the diagnosis of prostatic cancer].
    Varshavskiĭ SV; Martiushev AV; Fedina ID
    Urol Nefrol (Mosk); 1996; (4):36-9. PubMed ID: 8928349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tissue plasminogen activator in urine of patients with prostatic carcinoma and benign prostatic hyperplasia].
    Zietek Z; Iwan-Zietek I; Kotschy M; Wolski Z; Kulwas A; Białkowska A
    Pol Merkur Lekarski; 1997 Apr; 2(10):266-7. PubMed ID: 9377662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinicobiochemical study of diagnostic value of the panel including 10 potential protein markers of prostatic cancer].
    Shishkin SS; Dzeranov NK; Totrov KI; Kazachenko AV; Kovaleva MA; Toropygin IIu
    Urologiia; 2009; (1):56-8. PubMed ID: 19432234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population genetics of adenosine deaminase (EC: 3.5.4.4): gene frequencies in Southwestern Germany.
    Tariwerdian G; Ritter H
    Humangenetik; 1969; 7(2):179. PubMed ID: 5799495
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum adenosine deaminase activity in normal cattle.
    Hunt SE
    Br Vet J; 1970 Feb; 126(2):68-73. PubMed ID: 5503826
    [No Abstract]   [Full Text] [Related]  

  • 40. Free to total prostatic specific antigen ratio as a new diagnostic tool in prostatic carcinoma.
    Riccardo B; Alberino D; Fabrizio T; Gino C; Simone A; Guido B; Cesare S
    Anticancer Res; 1997; 17(2B):1297-301. PubMed ID: 9137489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.